Table 1.
Summary of MPC in 2 cases with combined APL.
| Case | 1 | 2 | |
|---|---|---|---|
| Solid tumor | Type | Adenocarcinoma of the lung | Hypofractionated adenocarcinoma of the stomach |
| Treatment modality | Surgery + chemotherapy | Surgery + chemotherapy | |
| Chemotherapy drug | Pemetrexed + cisplatin, gefitinib | Oxaliplatin + Tegeo, Oxaliplatin + Capecitabine | |
| Diagnosis of APL | 18 months after treatment | 17 months after treatment | |
| Diagnostic basis | MICM | MICM | |
| Cytogenetic characteristics | t (15;17) (q24;q21),add (18) (q23) | t (15;17) (q24;q21) | |
| Molecular characteristics | PML-RARα fusion gene: positive | PML-RARαS subtype (bcr-3) (+) with positive WT1 expression. | |
| Therapeutic regimen | Retinoic acid, compound Huang Dai | Retinoic acid, cytarabine | |
| APL survival time | 15days | 15days | |